Conception and design: Xiong, Chopp, Katakowski, Xin. Acquisition of data: Xiong, Zhang, Meng, Katakowski. Analysis and interpretation of data: all authors. Drafting the article: Xiong, Zhang, Chopp. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Xiong. Statistical analysis: Xiong, Zhang. Administrative/technical/material support: Xiong, Chopp, Katakowski, Xin, Mahmood. Study supervision: Xiong, Chopp, Katakowski, Xin.
Lu DMahmood AGoussev ASchallert TQu CZhang ZG: Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg 101:813–8212004
Nichols JENiles JADeWitt DPrough DParsley MVega S: Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury. Stem Cell Res Ther 4:32013
Schwab JMBeschorner RNguyen TDMeyermann RSchluesener HJ: Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrauma 18:377–3882001
Xin HChopp MShen LHZhang RLZhang LZhang ZG: Multipotent mesenchymal stromal cells decrease transforming growth factor β1 expression in microglia/macrophages and down-regulate plasminogen activator inhibitor 1 expression in astrocytes after stroke. Neurosci Lett 542:81–862013
Xiong YMahmood AMeng YZhang YQu CSchallert T: Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose. J Neurosurg 113:598–6082010
Xiong YMahmood AZhang YMeng YZhang ZGQu C: Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury. J Neurosurg 114:549–5592011